
|Articles|August 1, 2003
Supplements and Featured Publications
- Examining the Dyslipidemia Constellation
- Volume 9
- Issue 1 Dyslipid
Inflammatory markers are useful risk assessment tools
Author(s)Peter Libby, MD
Advertisement
Articles in this issue
over 22 years ago
NCEP ATP III guidelines incorporate global risk assessmentover 22 years ago
Case reports illustrate consequences of ATP III in practiceover 22 years ago
IVUS is redefining atherosclerotic diseaseNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Related Content
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
USDA and HHS Update Dietary Guidelines to Encourage Real Food, Less Sugar
2
HERIZON-GEA-01 Results Indicate Potential 1L Use of Zanidatamab for Gastroesophageal Adenocarcinoma
3
Social Determinants of Health Linked to Worse Outcomes in Hypertrophic Cardiomyopathy
4
CDC Vaccine Rollback Highlights Gaps in Public Understanding of Shared Decision-Making
5



























































